- (1) A licensing board shall not revoke, fail to renew, suspend, or take any action against a licensed health care provider based solely on the health care provider's recommendations to an eligible patient regarding access to or treatment with an investigational drug, biological product, or device.
- (2) The Cabinet for Health and Family Services shall not take action against a health care provider's Medicare or Medicaid certification based solely on the health care provider's recommendation that a patient have access to an investigational drug, biological product, or device.
Effective: June 29, 2017
History: Created 2017 Ky. Acts ch. 65, sec. 7, effective June 29, 2017. Formerly codified as KRS 217.5413.